NCT03261544

Brief Summary

The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique. The investigators hypothesize that those patients who receive reattachment of the abductors directly into the prosthesis will have better functional outcomes overall. Furthermore, the investigators plan to develop a simple, cost effective, and reproducible method to assess abductor function at clinical post-operative visits through plain radiographs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
31mo left

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Nov 2017Nov 2028

First Submitted

Initial submission to the registry

August 23, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 25, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

November 10, 2017

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

August 22, 2025

Status Verified

July 1, 2025

Enrollment Period

9.6 years

First QC Date

August 23, 2017

Last Update Submit

August 16, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • The Musculoskeletal Tumor Society (MSTS) score

    The Musculoskeletal Tumor Society (MSTS) score of extremity function. The total score ranges from 0 to 30, with higher scores indicating better function.

    up to 24 months postoperatively

  • Harris Hip Score

    The Harris Hip Score (HHS) is a clinician-based outcome measure that is frequently used for the evaluation of patients following a Total Hip Arthroplasty (THA). The survey has ten questions and scores ranging from 0-100, with higher scores representing less dysfunction and better outcomes.

    up to 24 months postoperatively

  • Number of patients with an implant-related complication as reported on the adverse event form upon participation completion.

    The adverse event form records the occurence of implant-related complications that occur during study participation.

    up to 24 months postoperatively

Secondary Outcomes (1)

  • Gait Analysis as reported on the study's case report form

    up to 24 months postoperatively

Study Arms (1)

Proximal Femur Replacement

The proximal femur is a common site for primary bone sarcomas and metastatic disease. The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique.

Procedure: Proximal Femur Replacement

Interventions

The purpose of this study is to assess the functional outcomes in patients undergoing proximal femur resection and reconstruction with an endoprosthesis, based on the abductor muscle repair technique.

Proximal Femur Replacement

Eligibility Criteria

Age16 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients treated for proximal femur replacements at Duke University Medical Center by Orthopaedic Oncology trained surgeons. The Duke DEDUCE database will be used to identify retrospective patients using the above mentioned CPT codes. Individual chart review of the electronic medical record will then be used to identify those receiving a proximal femur replacement. Maximum number of charts to be reviewed in the study will be 300. Of these 300 charts, the investigators plan to consent 25 subjects who have return appointments scheduled. The investigators also plan to consent 25 preoperative patients, for a total of 50 subjects.

You may qualify if:

  • Has undergone or is scheduled for proximal femur replacement by an Ortho Oncology surgeon

You may not qualify if:

  • Non-ambulatory before or after the procedure
  • Subjects who, in the opinion of the investigator, have not or likely will not complete at least some portion of the investigator's recommended follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University

Durham, North Carolina, 27710, United States

RECRUITING

MeSH Terms

Conditions

Sarcoma

Condition Hierarchy (Ancestors)

Neoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Study Officials

  • William Eward, MD, DVM

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth Sachs, MS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2017

First Posted

August 25, 2017

Study Start

November 10, 2017

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

November 1, 2028

Last Updated

August 22, 2025

Record last verified: 2025-07

Locations